>
EZZ Life Science Holdings logo

EZZ - EZZ Life Science Holdings Share Price

A$0.67 -0.0  -2.2%

Last Trade - 6:52am

Sector
Healthcare
Size
Micro Cap
Market Cap £16.0m
Enterprise Value £13.9m
Revenue £12.0m
Position in Universe 1371st / 1902
Bullish
Bearish
Unlock EZZ Revenue
Momentum
Relative Strength (%)
1m -17.8%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -51.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 11.2 18.0
+92.6
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020, EZZ LifeScience Holdings Ltd revenues increased 40% to A$12.7M. Netincome increased from A$372K to A$1.2M. Revenues reflectOther income increase from A$0K to A$136K. Net incomebenefited from Service fees decrease of 86% to A$21K(expense), Depreciation decrease of 11% to A$65K (expense),Interest expense on lease liabilities decrease of 35% toA$3K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

EZZ Revenue Unlock EZZ Revenue

Net Income

EZZ Net Income Unlock EZZ Revenue

Normalised EPS

EZZ Normalised EPS Unlock EZZ Revenue

PE Ratio Range

EZZ PE Ratio Range Unlock EZZ Revenue

Dividend Yield Range

EZZ Dividend Yield Range Unlock EZZ Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
EZZ EPS Forecasts Unlock EZZ Revenue
Profile Summary

EZZ Life Science Holdings Limited is an Australia-based consumer products company. The Company is wholesale distributor of EAORON skin care products for the Australian and New Zealand markets. It develops, manufactures and distributes genetic technology enabled consumer health products under its own brand, EZZ. The EAORON brand comprises of five product lines, including Hyaluronic Series, Facial Mask Series, Crystal White Series, Specific Care Series and Anti-Sugar Series. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, wright management and wellbeing, herbal/ traditional and pediatric consumer health products.

Directors
Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated September 22, 2015
Public Since March 3, 2021
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 42,000,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
EZZ Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for EZZ
Upcoming Events for EZZ
Frequently Asked Questions for EZZ Life Science Holdings
What is the EZZ Life Science Holdings share price?

As of 6:52am, shares in EZZ Life Science Holdings are trading at A$0.67, giving the company a market capitalisation of £16.0m. This share price information is delayed by 15 minutes.

How has the EZZ Life Science Holdings share price performed this year?

Shares in EZZ Life Science Holdings are currently trading at A$0.67 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the EZZ Life Science Holdings price has moved by % over the past year.

What are the analyst and broker recommendations for EZZ Life Science Holdings?

There are no analysts currently covering EZZ Life Science Holdings.

When will EZZ Life Science Holdings next release its financial results?

EZZ Life Science Holdings is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the EZZ Life Science Holdings dividend yield?

EZZ Life Science Holdings does not currently pay a dividend.

Does EZZ Life Science Holdings pay a dividend?

EZZ Life Science Holdings does not currently pay a dividend.

When does EZZ Life Science Holdings next pay dividends?

EZZ Life Science Holdings does not currently pay a dividend.

How do I buy EZZ Life Science Holdings shares?

To buy shares in EZZ Life Science Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of EZZ Life Science Holdings?

Shares in EZZ Life Science Holdings are currently trading at A$0.67, giving the company a market capitalisation of £16.0m.

Where are EZZ Life Science Holdings shares listed? Where are EZZ Life Science Holdings shares listed?

Here are the trading details for EZZ Life Science Holdings:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: EZZ
What kind of share is EZZ Life Science Holdings?

Based on an overall assessment of its quality, value and momentum, EZZ Life Science Holdings is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a EZZ Life Science Holdings share price forecast 2021?

We were not able to load any forecast data for EZZ Life Science Holdings.

How can I tell whether the EZZ Life Science Holdings share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like EZZ Life Science Holdings. Over the past six months, the relative strength of its shares against the market has been %. At the current price of A$0.67, shares in EZZ Life Science Holdings are trading at -15.02% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the EZZ Life Science Holdings PE Ratio?

The EZZ Life Science Holdings PE ratio based on its reported earnings over the past 12 months is 11.81. The shares are currently trading at A$0.67.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of EZZ Life Science Holdings?

We were unable to find the directors for EZZ Life Science Holdings.

Who are the major shareholders of EZZ Life Science Holdings?

Here are the top five shareholders of EZZ Life Science Holdings based on the size of their shareholding:

Macquarie Holdings Pty. Ltd. Corporation
Percentage owned: 40.51% (17.0m shares)
Qin (Qizhou Mark) Individual Investor
Percentage owned: 27.01% (11.3m shares)
Zheng (Haitao) Individual Investor
Percentage owned: 1.14% (480k shares)
Wang (Zhaoying) Individual Investor
Percentage owned: 1.14% (480k shares)
Chen (Jing) Individual Investor
Percentage owned: 1.14% (480k shares)
Similar to EZZ
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.